Clinical trial
The Efficacy of the Whisperflow CPAP System Versus High Flow Nasal Cannula Oxygen Therapy in Patients at High Risk for Postextubation Failure
NCT02918786 is registered in ClinicalTrials.gov with Ramathibodi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of the Whisperflow CPAP System Versus High Flow Nasal Cannula Oxygen Therapy in Patients at High Risk for Postextubation Failure
- Lead sponsor
- Ramathibodi Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 29, 2016
- Completion date
- March 31, 2017
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory failure